OncologyTube Professional - Patients Click Here
hematologydebates
5,392 video views
Loading........
Description: Ruben Niesvizky, MD, explains Incorporating Different Schedules into Combinations Use minimum active dose at Imedex Great Debates 2018.
02:56
Ruben Niesvizky, MD, explains Incorporating Different Schedules into Combinations Use minimum active dose at Imedex Great Debates 2018.
by:hematologydebates | 193 views
02:56
Ruben Niesvizky, MD, explains Quadruple Agents in Relapse Refractory Myeloma Capitalizing on synergy & lack of toxicities at Imedex Great Debates 2018.
by:hematologydebates | 157 views
01:46
Paul G. Richardson, MD, explains Adding to Lenalidomide to Make it Work Better Prednisone inhibitors, carfilzomib, and bortezomib at Imedex Great Debates 2018.
by:hematologydebates | 129 views
01:31
Paul G. Richardson, MD, explains One Size Does Not Fit All in Myeloma Clonal Tiding & Complex Heterogeneity at Imedex Great Debates 2018.
by:hematologydebates | 151 views
01:40
Paul G. Richardson, MD, explains Early Transplant Confers PFS Benefit, but Not Overall Stem cell transplant is an option at Imedex Great Debates 2018.
by:hematologydebates | 144 views
01:12
Paul G. Richardson, MD, explains Combinations with RVD Beyond Daratumumab Data with ixazomib, revlimid, & dexamethasone at Imedex Great Debates 2018.
by:hematologydebates | 130 views
03:44
Paul G. Richardson, MD, explains RVD-Lite Mission Treating Over 50 Patients Regimen of Bortezomib, lenalidomide, steroids at Imedex Great Debates 2018.
by:hematologydebates | 26 views
02:23
Paul G. Richardson, MD, explains Selinexor is a Novel Mechanism of Action Venetoclax Serves a Challenging Population at Imedex Great Debates 2018.
by:hematologydebates | 90 views
01:24
Paul G. Richardson, MD, explains Role of Venetoclax in Plasma Cell Leukemia Excellent partner drug with non-overlapping toxicities at Imedex Great Debates 2018.
by:hematologydebates | 66 views
00:59
Paul G. Richardson, MD, explains Powerful new IMiDs, CC-220 & CC-92480 Importance of Small Molecules in advanced trials at Imedex Great Debates 2018.
by:hematologydebates | 117 views

About hematologydebates


Links
Channel Url: